PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33001565-0	2021	Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.	Tranexamic Acid	79-94	plasminogen	Homo sapiens	17-24	
33001565-2	2021	TXA inhibits plasmin(ogen) binding to fibrin and reduces fibrinolysis.	Tranexamic Acid	0-3	plasminogen	Homo sapiens	13-20	
33001565-12	2021	For all doses of TXA administered intravenously, the PG assay detected delayed time-to-peak (<=3 hours) and reduced the velocity, peak, and endogenous plasmin potential (<=24 hours) in plasma samples obtained post-infusion.	Tranexamic Acid	17-20	plasminogen	Homo sapiens	151-158